News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

A closeup of a table with several leather chairs. On the table there are pieces of white paper with pens. In the background are windows. It is day outside.

INFORMS announces the results of the 2025 election for the Board of Directors. These new members will begin their tenure on the board beginning January 1, 2026.

Read More
On a blue background is white text and an orange logo in the bottom left corner. There is a circular photo of a woman on the left side. She has gray blonde hair, a black jacket and a pink collared shirt.

INFORMS has named Anna Nagurney, the Eugene M. Isenberg Chair in Integrative Studies at the University of Massachusetts Amherst, as the recipient of the 2025 INFORMS President’s Award.

Read More
Image of blue and orange data

INFORMS has named 12 distinguished leaders as 2025 INFORMS Fellows, one of the highest professional honors in operations research, analytics and AI.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565

INFORMS in the News

What are you looking for?

Type of Content
Topic
Vaccine Waste at 0.1% Fails to Ease the Worries of U.S. Doctors

Vaccine Waste at 0.1% Fails to Ease the Worries of U.S. Doctors

Bloomberg, April 22, 2021

States across the U.S. are reporting little waste of Covid-19 vaccine, in what appears to be evidence that careful handling of doses amid soaring demand is helping get almost every available shot into the arms of Americans.

Watch: A Stress Test for Supply Chains, Part 2

Watch: A Stress Test for Supply Chains, Part 2

Supply Chain Brain, April 19, 2021

David Simchi-Levi, professor of engineering systems at MIT, brings us up to date on the results of applying a supply-chain “stress test” to companies in multiple industries.

Johnson & Johnson COVID Vaccine Maker Emergent BioSolutions Asked To Stop Making Doses While FDA Investigation Underway

Johnson & Johnson COVID Vaccine Maker Emergent BioSolutions Asked To Stop Making Doses While FDA Investigation Underway

WJZ-TV 13, April 19, 2021

BALTIMORE (WJZ) — Emergent BioSolutions, the Baltimore, Maryland-based company manufacturing the Johnson & Johnson coronavirus vaccines, was asked to stop manufacturing COVID-19 related products, while the Food & Drug Administration continues its investigation into quality control issues at the plant that ruined 15 million potential doses of the vaccine.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine